Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

NanoRods

NanoRods
2007 FOUNDED
OOB STATUS
1-10 EMPLOYEES
Out of Business LATEST DEAL TYPE
Description

Manufacturer of gold nanorods intended to be used for nanotechnology based cancer therapeutics, diagnosis and sensing. The company's nanorods are used in certain electro-optical devices, as a contrast agent in optical tomography and photothermal cancer therapeutics, enabling customers from healthcare and sensing industries, to get smart and optically active nanomaterials for eliminating their technological barriers for the development of novel technologies with superior performances.

Website
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Devices and Supplies
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Primary Office
  • 12111 Parklawn Drive
  • Suite 106
  • Rockville, MD 20852
  • United States

+1 (240) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore NanoRods’s full profile, request a free trial.

NanoRods Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Oct-2017 00000 Completed Out of Business
3. Accelerator/Incubator 04-Feb-2010 00000 00000 Completed Generating Revenue
2. Grant 01-Jan-2010 $200K $74K Completed Generating Revenue
1. Early Stage VC 31-Dec-2008 $74K $74K Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

NanoRods Executive Team (2)

Name Title Board
Seat
Contact
Info
Babak Nikoobakht Founder, President, Chief Executive Officer & Advisor
Javier Goldin Chief Financial Officer